(S1 (S (S (PRN (-LRB- -LSB-) (NP (NP (NP (NN Expression)) (CC and) (NP (NN mutation))) (PP (IN of) (NP (NN c-kit) (NN gene))) (PP (IN in) (NP (JJ gastrointestinal) (JJ stromal) (NN tumor)))) (-RRB- -RSB-))) (. .)))
(S1 (S (NP (NP (NN OBJECTIVE)) (: :) (S (VP (TO To) (VP (VB investigate) (NP (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (DT the) (NP (NN expression)) (CC and) (NP (NN mutation))) (PP (IN of) (NP (NN c-kit) (NN gene)))))) (CC and) (NP (NP (PRP$ its) (NN relationship)) (PP (IN with) (NP (NP (NP (JJ clinical) (NN pathology)) (CC and) (NP (NN prognosis))) (PP (IN of) (NP (NP (JJ gastrointestinal) (JJ stromal) (NN tumor)) (PRN (-LRB- -LRB-) (NP (NN GIST)) (-RRB- -RRB-))))))))))) (. .))))
(S1 (S (NP (NP (NNS METHODS)) (: :) (S (NP (ADJP (ADJP (JJ Immunohistochemical)) (CC and) (ADJP (JJ PCR-SSCP))) (NNS techniques)) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VB detect) (NP (NP (NP (NN c-kit) (NN protein) (NN expression)) (CC and) (NP (NN c-kit) (NN gene) (NN exon) (CD 11) (NN mutation))) (PP (IN in) (NP (NP (CD 82) (NNS patients)) (PP (IN with) (NP (NN GIST)))))))))))) (. .))))
(S1 (S (NP (NP (NNS RESULTS)) (: :) (S (NP (DT The) (NP (NP (JJ positive) (NN c-kit) (NN protein) (NN expression)) (CC and) (NP (NN c-kit))) (NN gene) (NN mutation) (NNS rates)) (VP (VBD were) (NP (NP (NP (CD 97.6) (NN %)) (PRN (-LRB- -LRB-) (NP (NN 80/82)) (-RRB- -RRB-))) (CC and) (NP (NP (CD 41.5) (NN %)) (PRN (-LRB- -LRB-) (NP (NN 34/82)) (-RRB- -RRB-)))))) (. .))))
(S1 (S (PP (VBG Correlating) (NP (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (DT these) (CD two) (NNS methods)))) (CC and) (NP (JJ clinicopathological) (NNS factors)))) (, ,) (NP (DT the) (NP (NP (NN c-kit) (NN expression)) (CC and) (NP (NN c-kit))) (NN gene) (NN mutation) (NNS rates)) (VP (VP (VBD were) (NP (NP (NP (CD 95.0) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 19/20)) (-RRB- -RRB-))) (CC and) (NP (NP (CD 0)) (PP (IN in) (NP (JJ benign) (NN GIST)))))) (, ,) (CC and) (VP (VBD were) (NP (NP (NP (CD 98.4) (NN %)) (PRN (-LRB- -LRB-) (NP (NN 61/62)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (CD 54.8) (NN %)) (PRN (-LRB- -LRB-) (NP (NN 34/62)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ malignant) (NN GIST))))))) (. .)))
(S1 (S (S (NP (NN Mutation) (JJ positive) (NN GIST)) (VP (VBD showed) (NP (NP (JJR higher) (NN frequency)) (PP (IN of) (NP (NP (JJ adjacent) (NN tissue) (NN invasion)) (, ,) (NP (NN metastasis)) (CC and) (NP (NN recurrence))))) (SBAR (IN as) (S (VP (VBN compared) (PP (IN with) (NP (NN mutation) (JJ negative) (NNS ones)))))))) (. .)))
(S1 (S (NP (NP (NN CONCLUSION)) (: :) (S (NP (NN c-kit) (NN protein)) (VP (VBZ is) (NP (NP (DT an) (JJ important) (JJ diagnostic) (NN marker)) (PP (IN of) (NP (JJ gastrointestinal) (JJ stromal) (NN tumor)))))) (. .))))
(S1 (S (S (NP (NN c-kit) (NN gene) (NN mutation)) (VP (VP (MD may) (VP (VB play) (NP (DT a) (JJ significant) (NN role)) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NN GIST))))))) (CC and) (ADVP (RB also)) (VP (MD may) (VP (VB be) (NP (DT a) (JJ prognostic) (NN marker)))))) (. .)))
